• S1E3 - SGLT-2 Inhibitors Morning Commute: Optimizing Benefit in CKD Management

  • Feb 27 2021
  • Length: 25 mins
  • Podcast

S1E3 - SGLT-2 Inhibitors Morning Commute: Optimizing Benefit in CKD Management

Listen for free

View show details

  • Summary

  • Visit http://morningcommutepodcast.com/SGLT2inhibitors3 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode, our experts will focus on chronic kidney disease (CKD) in patients with or without diabetes and treatment with sodium-glucose cotransporter 2 (SGLT-2) inhibitors. The bottom line is, how should these treatments be incorporated into clinical practice?
    Show More Show Less
Show More Show Less
activate_samplebutton_t1

What listeners say about S1E3 - SGLT-2 Inhibitors Morning Commute: Optimizing Benefit in CKD Management

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.